Circulating fibronectin affects bone matrix, whereas osteoblast fibronectin modulates osteoblast function

Journal of Bone and Mineral Research

Volumn 25, Issue 4, 2010, Pages 706-715

  Bentmann, Anke ^a,b   Kawelke, Nina ^a,b   Moss, David ^c   Zentgraf, Hanswalter ^d   Bala, Yohann ^e   Berger, Irina ^b   Gasser, Juerg A ^f   Nakchbandi, Inaam A ^a,b  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e UNIVERSITÉ LYON 1   (France)

^f NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Bone formation; Bone matrix; Fibronectin; Liver; Osteoblast

Indexed keywords

BETA1 INTEGRIN; COLLAGEN TYPE 1; FIBRONECTIN;

ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE DENSITY; BONE MATRIX; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; LIVER; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PROTEIN BINDING; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD29; BONE DENSITY; BONE MATRIX; CELL DIFFERENTIATION; COLLAGEN; EXTRACELLULAR MATRIX; FEMALE; FIBRONECTINS; LIVER; MALE; MICE; MICE, TRANSGENIC; OSTEOBLASTS;

EID: 77953453508     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.091011     Document Type: Article

References (40)

1. Burr D, Turner C. Biomechanics of bone. In: Favus M, ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 5th ed. Washington, DC: American Society for Bone and Mineral Research; 2003:58-64.
2. Robey P, Boskey AL. The biochemistry of bone. In: Marcus R, Feldman D, Kelsey J, eds. Osteoporosis. San Diego: Academic Press; 1996:95-183.
3. Stein GS, Lian JB, Stein JL, Van Wijnen AJ, Montecino M. Transcriptional control of osteoblast growth and differentiation. Physiol Rev. 1996;76:593-629. (Pubitemid 26163716)
4. Velling T, Risteli J, Wennerberg K, Mosher DF, Johansson S. Polymerization of type I and III collagens is dependent on fibronectin and enhanced by integrins a11b1 and a2b1. J Biol Chem. 2002;277: 37377-37381.
5. Stein GS, Lian JB. Molecular mechanisms mediating proliferation/ differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev. 1993;14:424-442.
6. Sottile J, Hocking DC. Fibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cell-matrix adhesions. Mol Biol Cell. 2002;13:3546-3559. (Pubitemid 35191374)
7. Whyte M. Osteogenesis imperfecta. In: Favus M, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. Philadelphia: Lippincott Williams and Wilkins; 1999:470-473.
8. McKee M, Farach-Carson M, Butler W, Hauschka P, Nanci A. Ultrastructural immunolocalization of noncollagenous (osteopontin and osteocalcin) and plasma (albumin and alpha 2HS-glycoprotein) proteins in rat bone. J Bone Miner Res. 1993;8:485-496. (Pubitemid 23105845)
9. Triffitt JT, Gebauer U, Ashton BA, Owen ME, Reynolds JJ. Origin of plasma alpha2HS-glycoprotein and its accumulation in bone. Nature. 1976;262:226-227.
10. Moursi AM, Damsky CH, Lull J, Zimmerman D, Doty SB, Aota S, Globus RK. Fibronectin regulates calvarial osteoblast differentiation. J Cell Sci. 1996;109:1369-1380. (Pubitemid 26190487)
11. Moursi AM, Globus RK, Damsky CH. Interactions between integrin receptors and fibronectin are required for calvarial osteoblast differentiation in vitro. J Cell Sci. 1997;110:2187-2196.
12. Chen Q, Zhao J, Dallas MR, Fassler R, Peters DM, Dallas SL. Fibronectin plays a role in osteoblast differentiation which may be mediated via regulation of BMP activity. J Bone Mineral Res. 2006;21:s13.
13. Hynes R. Structure of fibronectins. In: Rich A, ed. Fibronectins. New York: Springer; 1990:113-175.
14. Matsuura H, Takio K, Titani K, Greene T, Levery SB, Salyan ME, Hakomori S. The oncofetal structure of human fibronectin defined by monoclonal antibody FDC-6. Unique structural requirement for the antigenic specificity provided by a glycosylhexapeptide. J Biol Chem. 1988;263:3314-3322. (Pubitemid 18072789)
15. Hynes R. Distribution of Fibronectins in vivo: Plasma. In: Rich A, ed. Fibronectins. New York: Springer; 1990:27-30.
16. Leiss M, Beckmann K, Giros A, Costell M, Fassler R. The role of integrin binding sites in fibronectin matrix assembly in vivo. Curr Opin Cell Biol. 2008;20:502-507.
17. Grzesik W, Robey P. Bone matrix RGD glycoproteins: immunolocalization and interaction with human primary osteoblastic bone cells in vitro. J Bone Miner Res. 1994;9:487-496. (Pubitemid 24090331)
18. Cheng SL, Lai CF, Fausto A, Chellaiah M, Feng X, McHugh KP, Teitelbaum SL, Civitelli R, Hruska KA, Ross FP, Avioli LV. Regulation of αVβ3 and αVβ5 integrins by dexamethasone in normal human osteoblastic cells. J Cell Biochem. 2000;77:265-276.
19. Pistone M, Sanguineti C, Federici A, Sanguineti F, Defilippi P, Santolini F, Querze G, Marchisio P, Manduca P. Integrin synthesis and utilization in cultured human osteoblasts. Cell Biol Int. 1996;20:471-479. (Pubitemid 26379886)
20. Saito T, Albelda S, Brighton C. Identification of integrin receptors on cultured human bone cells. J Orthop Res. 1994;12:384-394. (Pubitemid 24181142)
21. George EL, Georges-Labouesse EN, Patel-King RS, Rayburn H, Hynes RO. Defects inmesoderm, neural tube and vascular development inmouse embryos lacking fibronectin. Development. 1993;119:1079-1091. (Pubitemid 23358578)
22. Aszodi A, Hunziker EB, Brakebusch C, Fassler R. Beta1 integrins regulate chondrocyte rotation, G1 progression, and cytokinesis. Genes Dev. 2003;17:2465-2479.
23. Sakai T, Johnson K, Murozono M, Sakai K, Magnuson M, Wieloch T, Cronberg T, Isshiki A, Erickson H, Fassler R. Plasma fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis. Nature Medicine. 2001;7:324-330. (Pubitemid 32224348)
24. Dacquin R, Starbuck M, Schinke T, Karsenty G. Mouse α1(I)-collagen promoter is the best known promoter tp drive efficient Cre recombinase expression in osteoblasts. Develpmental Dynamics. 2002;224:245-251.
25. Constien R, Forde A, Liliensiek B, Grone HJ, Nawroth P, Hammerling G, Arnold B. Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line. Genesis. 2001;30:36-44.
26. Takahashi S, Leiss M, Moser M, Ohashi T, Kitao T, Heckmann D, Pfeifer A, Kessler H, Takagi J, Erickson HP, Fassler R. The RGD motif in fibronectin is essential for development but dispensable for fibril assembly. J Cell Biol. 2007;178:167-178. (Pubitemid 47026411)
27. Kawelke N, Bentmann A, Hackl N, Hager HD, Feick P, Geursen A, Singer MV, Nakchbandi IA. Isoform of fibronectin mediates bone loss in patients with primary biliary cirrhosis by suppressing bone formation. J Bone Miner Res. 2008;23:1278-1286. (Pubitemid 352040182)
28. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987;2:595-610.
29. Boskey AL, Goldberg M, Kulkarni A, Gomez S. Infrared imaging microscopy of bone: illustrations from a mouse model of Fabry disease. Biochim Biophys Acta. 2006;1758:942-947.
30. Boivin G, Bala Y, Doublier A, Farlay D, Ste-Marie LG, Meunier PJ, Delmas PD. The role of mineralization and organic matrix in the microhardness of bone tissue from controls and osteoporotic patients. Bone. 2008;43:532-538.
31. Zentgraf H, Franke WW. Differences of supranucleosomal organization in different kinds of chromatin: cell type-specific globular subunits containing different numbers of nucleosomes. J Cell Biol. 1984;99:272-286. (Pubitemid 14096891)
32. Chung DJ, Castro CH, Watkins M, Stains JP, Chung MY, Szejnfeld VL, Willecke K, Theis M, Civitelli R. Low peak bone mass and attenuated anabolic response to parathyroid hormone in mice with an osteoblast-specific deletion of connexin43. J Cell Sci. 2006;119:4187-4198.
33. Manabe R, Ohe N, Maeda T, Fukuda T, Sekiguchi K. Modulation of cell-adhesive activity of fibronectin by the alternatively spliced EDA segment. J Cell Biol. 1997;139:295-307. (Pubitemid 27444099)
34. Liao YF, Gotwals P, Koteliansky VE, Sheppard D, Van De Water L. The EIIIA segment of fibronectin is a ligand for integrins α9β1 and α4β1 providing a novel mechanism for regulating cell adhesion by alternative splicing. J Biol Chem. 2002;277:14467-14474.
35. Mould AP, Komoriya A, Yamada KM, Humphries MJ. The CS5 peptide is a second site in the IIICS region of fibronectin recognized by the integrin α4β1: inhibition of α4β1 function by RGD peptide homologues. J Biol Chem. 1991;266:3579-3585.
36. Grabner B, Landis WJ, Roschger P, Rinnerthaler S, Peterlik H, Klaushofer K, Fratzl P. Age- and genotype-dependence of bone material properties in the osteogenesis imperfecta murine model (oim). Bone. 2001;29:453-457. (Pubitemid 33026466)
37. McBride DJ Jr, Choe V, Shapiro JR, Brodsky B. Altered collagen structure in mouse tail tendon lacking the a2(I) chain. J Mol Biol. 1997;270:275-284. (Pubitemid 27296687)
38. Cassella JP, Barber P, Catterall AC, Ali SY. A morphometric analysis of osteoid collagen fibril diameter in osteogenesis imperfecta. Bone. 1994;15:329-334. (Pubitemid 24361046)
39. Leslie WD, Bernstein CN, Leboff MS. AGA technical review on osteoporosis in hepatic disorders. Gastroenterology. 2003;125:941-966. (Pubitemid 37070710)
40. Manabe R, Oh-e N, Sekiguchi K. Alternatively spliced EDA segment regulates fibronectin-dependent cell cycle progression and mitogenic signal transduction. J Biol Chem. 1999;274:5919-5924. (Pubitemid 29109250)